Are We Close to a Cure for Waldenstrom Macroglobulinemia? Waldenstrom expert, Dr. Steven Treon, shares how the advancements in Waldenstrom macroglobulinemia treatment are vastly improving survivorship and paving the way to a cure. Andrew Schorr, Steven Treon, MD
When Should a Patient Seek Treatment for Waldenstrom Macroglobulinemia? Approximately 30% of newly diagnosed Waldenstrom patients are "watch and wait." When is it time to start treatment? Andrew Schorr, Steven Treon, MD
Maintenance Therapy for Waldenstrom: Necessary or Not? Larry Anderson, Jr., MD, PhD, Theresa Clementi Doan
Waldenstrom Patients Benefit From Treatments Developed for Myeloma and Lymphoma James R. Berenson, MD, Esther Schorr
Treating Waldenstrom With Targeted Therapies Frits van Rhee, MD, PhD, FACP, MRCP, FRCPath, Dan Vogl, MD